Ted Okon, MBA is a nationally recognized expert on the policy and politics of cancer care. He has testified before Congress on cancer issues and is frequently on Capitol Hill discussing the nation’s cancer care delivery system. Ted’s target areas of expertise include the cost of cancer treatment, health care reform, Medicare reimbursement, drug shortages, and the changing landscape of cancer care delivery in the United States.
Ted has dedicated his career to health care business and policy. He has worked for several pharmaceutical companies including Merck and Warner Lambert, now part of Pfizer, and IMS Health. Ted co-founded and took public the health care information business Medical Marketing Group. He also founded two oncology companies and has traveled extensively to China, India, Singapore, the U.K., and the Middle East, analyzing and discussing cancer care delivery.
As Executive Director of the Community Oncology Alliance (COA), Ted oversees the strategic direction of this non-profit organization dedicated to patients and providers in the community cancer care setting, under the direction of a dedicated board of oncologists and practice administrators. He also travels the country speaking to state oncology societies, professional organizations, and companies about the challenges facing the nation’s cancer care delivery system. He has authored numerous articles and studies relating to cancer care policy and politics, reimbursement, and clinical issues.
Ted holds a BS degree from Fairfield University and an MBA from the Carnegie-Mellon University Tepper School of Business. His wife is a full-time practicing oncology nurse.